We aim to eliminate the public health threat of infectious diseases by supporting the global elimination targets in the United Nations Sustainable Development Goals.
We're an interdisciplinary team of clinicians, epidemiologists, social scientists and public health practitioners. Our aim is to improve our understanding of infectious diseases and their transmission, prevention, care and cure. We focus on prevention, diagnosis and management of blood borne viruses for people living with these diseases. This includes viral hepatitis and HIV.
We examine novel models of care and conduct clinical trials based on implementation science. The goal is to increase knowledge and improve health outcomes for affected communities.
We work closely with affected populations including:
We also engage and collaborate with:
Our health outcomes have led to changes in national and global guidelines in testing, care and treatment for communities living with infectious diseases.
To improve the health of people living with infectious diseases, we've directly supported:
People with hepatocellular carcinoma risk factors are recommended to have twice-yearly cancer screenings. We explore barriers to screening adherence.
Expanding access to hepatitis C testing and treatment using a pharmacy-based model.
Partnering to eliminate hepatitis C as a public health threat by 2030.
This project assesses the effectiveness, feasibility and cost-effectiveness of nurse-led testing and treatment of hepatitis C in community pharmacies for people on opiate substitution therapy.
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.